Moderate to Severe Dry Eye Syndrome
Conditions
Brief summary
This clinical trial is to investigate whether nonsteroid anti-inflammatory drops have therapeutic effect on moderate to severe dry eye patients.And compare the efficacy of the two nonsteroid anti-inflammatory drops with topical corticosteroids.
Interventions
nonsteroid anti-inflammatory drops plus artificial tear substitute
corticosteroids plus artificial tear substitute
artificial tear substitute alone
Sponsors
Study design
Eligibility
Inclusion criteria
* moderate to severe dry eye syndrome * tear film breakup time \>0 second and ≤5 seconds,or schirmer test(no anaesthesia)≥2mm/5min and ≤5mm/5min * corneal staining≥3 scores
Exclusion criteria
* allergic to any composition of the drugs under experiment * previous use of anti-inflammatory drugs or immunosuppressive agent * viral,bacterial or fungal infection of the eye * eyelid anomaly * glaucoma or high IOP * significant meibomian gland dysfunction
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| tear osmolarity | Day 0, Day 14 |
Secondary
| Measure | Time frame |
|---|---|
| corneal staining | 0 day,7th day and 14th day after treatment |
| Schirmer test(without anaesthesia) | 0 day,7th day,14th day after treatment |
| tear film breakup time(TBUT) | 0 day,7th day and 14th day after treatment |
| meibomian gland function | 0 day,7th day and 14th day after treatment |
Countries
China